EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Optimized Ex Vivo Human Liver Slice Culture Maintains Extended Viability and Function for Hepatotoxicity Testing

Huiche Feng, Cinzia Esposito, Andrej Benjak, Matthias S Matter, Miriam Cieri, Camilla De Carlo, Philipp Sedlaczek, Fabian Haak, Mattia Marinucci, Gabriel Fridolin Hess, Otto Kollmar, Mairene Coto-Llerena und 6 weitere

Advanced Science · 2026

DOI: 10.1002/advs.202523976 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, 2026. Verfasst von Huiche Feng und 17 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Pathology, University Hospital Basel, Basel, Switzerland. Hauptthemen laut MEDLINE: Liver, Chemical and Drug Induced Liver Injury, Hepatocytes, Tissue Culture Techniques. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 89 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Basel, AIRC - Fondazione AIRC per la Ricerca sul Cancro, European Union - NextGenerationEU, Italian Ministry of University and Research (MUR), PNRR - Mission 4 Component 2 Investment 1.4, National Centre for HPC, Big….

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Human precision‐cut liver slices (hPCLS) are widely used to study liver physiology and disease, but their short lifespan limits long‐term functional studies and drug testing. Here, we describe an optimized ex vivo culture system, hPCLS‐EV (Extended Viability), that maintains tissue viability, cellular composition, and liver‐specific functions for up to five days. Optimization combined reduced slice thickness, high oxygen partial pressure, and air‐liquid interface culture, preserving hepatocyte integrity, stromal stability, and immune cell populations. Functional assays confirmed sustained albumin secretion, glutathione content, and cytochrome P450 activity. Transcriptomic profiling revealed rapid downregulation of metabolic pathways by day 3, followed by stabilization up to day 5, with limited advanced injury or fibrosis‐related remodeling. We applied hPCLS‐EV to model drug‐induced liver injury using acetaminophen and troglitazone. The model captured compound‐specific injury patterns, including early glutathione depletion with acetaminophen and delayed oxidative stress with troglitazone. Together, these findings support optimized hPCLS‐EV as a useful ex vivo human liver model that preserves key tissue architecture and selected liver functions over an extended culture period, enabling longitudinal assessment of hepatotoxic injury. This platform may provide a useful experimental tool for preclinical hepatotoxicity testing, mechanistic studies of liver injury, and patient‐specific applications in precision medicine.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LiverChemical and Drug Induced Liver InjuryHepatocytesTissue Culture TechniquesTissue SurvivalHumansAcetaminophenOxidative StressOrgan Culture TechniquesGlutathione

Stichwörter der Autor:innen

drug‐induced liver injuryex vivo liver modelextended tissue viabilityhepatotoxicity testinghuman precision‐cut liver slices

Substanzen

AcetaminophenGlutathione

Autor:innen und Institutionen

  • Institute of Pathology, University Hospital Basel, Basel, Switzerland.
  • Department for BioMedical Research (DBMR), University of Bern, Bern, Switzerland.
  • IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.
  • Clarunis, Department of Visceral Surgery, University Center for Gastrointestinal and Liver Diseases, St. Clara Hospital and University Hospital Basel, Basel, Switzerland.
  • Department of Visceral, Transplant, Thoracic and Vascular Surgery, University Hospital of Leipzig, Leipzig, Germany.
  • Visceral Surgery and Precision Medicine Research Laboratory, Department of Biomedicine, University of Basel, Basel, Switzerland.

ORCID-Profile: Salvatore Piscuoglio

Förderung

  • University of Basel
  • AIRC - Fondazione AIRC per la Ricerca sul Cancro
  • European Union - NextGenerationEU, Italian Ministry of University and Research (MUR), PNRR - Mission 4 Component 2 Investment 1.4, National Centre for HPC, Big…
  • Universität Basel

Zitieren

APA

Feng, H., Esposito, C., Benjak, A., Matter, M. S., Cieri, M., De Carlo, C., Sedlaczek, P., Haak, F., Marinucci, M., Hess, G. F., Kollmar, O., Coto-Llerena, M., Di Tommaso, L., Vela, V., Bubendorf, L., Terracciano, L. M., Ng, C. K. Y., & Piscuoglio, S. (2026). Optimized Ex Vivo Human Liver Slice Culture Maintains Extended Viability and Function for Hepatotoxicity Testing. Advanced Science. https://doi.org/10.1002/advs.202523976

Vancouver

Feng H, Esposito C, Benjak A, Matter MS, Cieri M, De Carlo C, et al. Optimized Ex Vivo Human Liver Slice Culture Maintains Extended Viability and Function for Hepatotoxicity Testing. Advanced Science. 2026. doi:10.1002/advs.202523976

BibTeX
@article{Feng2026,
  author = {Feng, Huiche and Esposito, Cinzia and Benjak, Andrej and Matter, Matthias S and Cieri, Miriam and De Carlo, Camilla and Sedlaczek, Philipp and Haak, Fabian and Marinucci, Mattia and Hess, Gabriel Fridolin and Kollmar, Otto and Coto-Llerena, Mairene and Di Tommaso, Luca and Vela, Visar and Bubendorf, Lukas and Terracciano, Luigi M and Ng, Charlotte K Y and Piscuoglio, Salvatore},
  title = {Optimized Ex Vivo Human Liver Slice Culture Maintains Extended Viability and Function for Hepatotoxicity Testing},
  journal = {Advanced Science},
  year = {2026},
  doi = {10.1002/advs.202523976}
}
Kostenlos starten →